369 related articles for article (PubMed ID: 23667480)
1. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.
Ozcelik S; Fraser G; Castets P; Schaeffer V; Skachokova Z; Breu K; Clavaguera F; Sinnreich M; Kappos L; Goedert M; Tolnay M; Winkler DT
PLoS One; 2013; 8(5):e62459. PubMed ID: 23667480
[TBL] [Abstract][Full Text] [Related]
2. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
[TBL] [Abstract][Full Text] [Related]
3. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
[TBL] [Abstract][Full Text] [Related]
4. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin ester analog CCI-779/Temsirolimus alleviates tau pathology and improves motor deficit in mutant tau transgenic mice.
Frederick C; Ando K; Leroy K; Héraud C; Suain V; Buée L; Brion JP
J Alzheimers Dis; 2015; 44(4):1145-56. PubMed ID: 25408212
[TBL] [Abstract][Full Text] [Related]
6. Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice.
Zhu Y; Zhan G; Fenik P; Brandes M; Bell P; Francois N; Shulman K; Veasey S
J Neurosci; 2018 Nov; 38(48):10255-10270. PubMed ID: 30322903
[TBL] [Abstract][Full Text] [Related]
7. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.
Ohia-Nwoko O; Montazari S; Lau YS; Eriksen JL
Mol Neurodegener; 2014 Nov; 9():54. PubMed ID: 25432085
[TBL] [Abstract][Full Text] [Related]
8. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.
Rodríguez-Navarro JA; Rodríguez L; Casarejos MJ; Solano RM; Gómez A; Perucho J; Cuervo AM; García de Yébenes J; Mena MA
Neurobiol Dis; 2010 Sep; 39(3):423-38. PubMed ID: 20546895
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.
Schaeffer V; Lavenir I; Ozcelik S; Tolnay M; Winkler DT; Goedert M
Brain; 2012 Jul; 135(Pt 7):2169-77. PubMed ID: 22689910
[TBL] [Abstract][Full Text] [Related]
10. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
[TBL] [Abstract][Full Text] [Related]
11. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
12. Piericidin A aggravates Tau pathology in P301S transgenic mice.
Höllerhage M; Deck R; De Andrade A; Respondek G; Xu H; Rösler TW; Salama M; Carlsson T; Yamada ES; Gad El Hak SA; Goedert M; Oertel WH; Höglinger GU
PLoS One; 2014; 9(12):e113557. PubMed ID: 25437199
[TBL] [Abstract][Full Text] [Related]
13. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
[TBL] [Abstract][Full Text] [Related]
14. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
Siman R; Cocca R; Dong Y
PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
[TBL] [Abstract][Full Text] [Related]
15. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions.
Sidoryk-Wegrzynowicz M; Gerber YN; Ries M; Sastre M; Tolkovsky AM; Spillantini MG
Acta Neuropathol Commun; 2017 Nov; 5(1):89. PubMed ID: 29187256
[TBL] [Abstract][Full Text] [Related]
16. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
Mewes A; Franke H; Singer D
PLoS One; 2012; 7(9):e45017. PubMed ID: 22984603
[TBL] [Abstract][Full Text] [Related]
17. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
18. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo.
Congdon EE; Wu JW; Myeku N; Figueroa YH; Herman M; Marinec PS; Gestwicki JE; Dickey CA; Yu WH; Duff KE
Autophagy; 2012 Apr; 8(4):609-22. PubMed ID: 22361619
[TBL] [Abstract][Full Text] [Related]
19. Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.
Antón-Fernández A; Merchán-Rubira J; Avila J; Hernández F; DeFelipe J; Muñoz A
J Alzheimers Dis; 2017; 60(2):651-661. PubMed ID: 28922155
[TBL] [Abstract][Full Text] [Related]
20. α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice.
Zhang YH; Wang DW; Xu SF; Zhang S; Fan YG; Yang YY; Guo SQ; Wang S; Guo T; Wang ZY; Guo C
Redox Biol; 2018 Apr; 14():535-548. PubMed ID: 29126071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
